Healthcare - Biotechnology - NASDAQ - US
$ 4.85
-8.66 %
$ 194 M
Market Cap
-1.6
P/E
Price Target
Average
260.82%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
23.40%
Net Income
Estimate
41.00%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Solid Biosciences Inc.
Wall Street analysts predict an average 1-year price target for SLDB of $17.5 , with forecasts ranging from a low of $12 to a high of $20 .
SLDB Lowest Price Target
Wall Street Target
12 USD
147.42%
SLDB Average Price Target
Wall Street Target
17.5 USD
260.82%
SLDB Highest Price Target
Wall Street Target
20 USD
312.37%
REVENUE FORECAST
Revenue Forecast Chart SLDB
EBIT FORECAST
EBIT Forecast Chart SLDB
NET INCOME FORECAST
Net Income Chart SLDB